UTI AMC has announced that its board of directors will convene on April 23, 2026, to review and approve the company's audited financial results for the fourth quarter and full financial year ending March 31, 2026. The meeting notification was issued on March 20, 2026, in accordance with regulatory compliance requirements.

Board Meeting Agenda

The upcoming board meeting will address several key corporate matters as outlined in the official communication:

Trading Window Closure

In compliance with insider trading regulations, the company has announced a trading window closure for designated persons and their immediate relatives. The trading restrictions will be effective from April 1, 2026, to April 25, 2026 (both days inclusive).

Regulatory Compliance

The board meeting intimation has been issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results and dividend recommendations are to be considered.

The company has ensured compliance with Regulation 46 of the SEBI Listing Regulations by making this intimation available on its official website at www.utimf.com . Additionally, the company has confirmed compliance with relevant SEBI circulars by freezing the PAN of designated persons and updating the window closure dates with Central Depository Services (India) Limited.

Corporate Communication Details

The official communication was signed by Arvind Patkar, Company Secretary and Compliance Officer, who holds membership number ACS 21577. The intimation was digitally signed on March 20, 2026, and sent to both major stock exchanges where the company's shares are listed.

The notification was addressed to the National Stock Exchange of India Limited and BSE Limited, where UTI Asset Management Company Limited trades under the symbol UTIAMC. This formal communication ensures that all stakeholders, including investors and regulatory bodies, are informed about the scheduled board meeting and trading restrictions well in advance.

UTI AMC has announced the allotment of 906 equity shares under its Employee Stock Option Scheme – 2007, following approval from the company's Nomination and Remuneration Committee on March 9, 2026. The allotment was approved at 1106 hrs IST pursuant to the exercise of options by eligible employees under the scheme.

Share Capital Enhancement

The allotment has resulted in an increase in the company's issued and paid-up share capital structure. The following table details the capital changes:

Regulatory Compliance and Disclosure

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI master circular dated January 30, 2026. The company communicated the development to both the National Stock Exchange of India Limited and BSE Limited through reference number UTI/AMC/CS/SE/2025-26/0646.

Share Rights and Characteristics

The newly allotted equity shares carry identical rights and privileges as the existing equity shares. These shares will rank pari-passu in all respects with the current equity shares of the company. Each share maintains a face value of ₹10, consistent with the existing share structure.

ESOP Scheme Details

The allotment was executed under the UTI AMC Employee Stock Option Scheme – 2007, which provides eligible employees with the opportunity to acquire equity shares in the company. The scheme represents part of the company's employee compensation and retention strategy, allowing employees to participate in the company's equity growth.